Opendata, web and dolomites

Sea4Pain SIGNED

Development of a novel analgesic for chronic pain from marine-derived compounds

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 Sea4Pain project word cloud

Explore the words cloud of the Sea4Pain project. It provides you a very rough idea of what is the project "Sea4Pain" about.

sea4us    team    sensing    toxicity    525    supporting    founded    moderate    limited    constantly    drive    alleviate    portuguese    compound    extremely    capital    class    13    give    pain    addiction    health    marine    co    shows    alternative    channels    venture    inflict    drug    strategy    market    acting    efficacy    modulator    2022    drugs    pathologies    biotechnological    series    adverse    ion    crowdfunding    action    applies    brain    51    habituation    first    derivate    suffering    modulate    received    kv    chronic    noxious    2013    patented    severe    derivatives    fifth    pharmaceuticals    population    250    compounds       quality    demonstrated    global    analgesic    channel    lab    switch    neurons    patients    mode    huge    disruptive    ease    benefits    grants    biomedicine    pharmaceutical    world    worth    raised    professionals    innovative    opioid    roll    billion    life    suffer    expand    treatments    38    breakthroughs    sea4pain    differentiated    platform    discovery    cagr    2015   

Project "Sea4Pain" data sheet

The following table provides information about the project.

Coordinator
SEA4US BIOTECNOLOGIA E RECURSOS MARINHOS LDA 

Organization address
address: RUA DO POENTE S/N
city: SAGRES
postcode: 8650 378
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Portugal [PT]
 Project website http://sea4us.pt/en/
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2018
 Duration (year-month-day) from 2018-05-01   to  2018-09-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    SEA4US BIOTECNOLOGIA E RECURSOS MARINHOS LDA PT (SAGRES) coordinator 50˙000.00

Map

 Project objective

'The Sea4Pain project will expand and define the development strategy for Sea4Us’s “Drug Discovery and Development Platform” – a platform that applies novel biotechnological approaches to exploit marine derived compounds for the development of novel pharmaceuticals highly relevant for biomedicine. The first lab-based research results have clearly demonstrated the benefits of marine compounds in a series of pathologies, like chronic pain, and the huge potential of its derivate products in the health market. In particular, our innovative breakthroughs will lead to the development of a unique, high efficacy analgesic (ion channel modulator), with reduced toxicity and limited side-effects (Sea4Pain). This extremely innovative approach shows a differentiated mode-of-action (acting directly in the 'pain switch'), that will give rise to a new class of pharmaceutical drugs with no expected adverse effects on the brain (currently being patented). The disruptive compound will modulate specific ion channels in pain-sensing neurons (Kv), for which there is no known modulator, and ease the suffering of one fifth of the World's population who constantly suffer from chronic pain. Sea4Pain will offer alternative treatments for patients suffering from moderate to severe chronic pain. Current drugs in the market (opioid derivatives and others) do alleviate pain but co-inflict important noxious effects (habituation, addiction, loss of drive) and great loss in quality of life. The global pain management drugs and devices market was estimated to be worth $38 billion in 2015 and reach $51 billion in 2022 at a CAGR of 4%. Founded in 2013, Sea4Us has received over 525.000€ in Portuguese and European Research Grants, raised 10.000€ with crowdfunding, and 250.000€ in venture capital, supporting a team of 13 professionals and is focused on developing the Sea4Pain roll-to-market of innovative treatments.'

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "SEA4PAIN" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "SEA4PAIN" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

Dyme (2019)

Dyme gives its users complete control over their financial situation. The Dyme application provides insight into users’ spending and subscriptions, and lets users cancel, negotiate, or switch any cont

Read More  

DeltaQon (2019)

IOT and cloud computing for online medical analysis service platform

Read More  

Presque (2019)

Smart Nursing Bra

Read More